Kai Chen
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
- Oncology 70
- Peptidase Inhibition and Analysis 18
- Co-authors
- Qizhen Cao (11 shared papers)Jin Xie (12 shared papers)Weibo Cai (17 shared papers)Zibo Li (22 shared papers)Peter S. Conti (25 shared papers)John F. Keaney (8 shared papers)Xiaoyuan Chen (8 shared papers)Zhen Cheng (11 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (10 papers)Amino Acids (9 papers)Frontiers in Oncology (7 papers)Journal of Nuclear Medicine (6 papers)Oncotarget (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Kai Chen
423 papers receiving 16.7k citations
Kai Chen's Hit Papers
Peers
Comparison fields: 5 of 184
- Biomaterials 3.4k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Immunology and Allergy 616
- Cancer Research 1.4k
- Biomedical Engineering 4.3k
Countries citing papers authored by Kai Chen
This map shows the geographic impact of Kai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Chen more than expected).
Fields of papers citing papers by Kai Chen
This network shows the impact of papers produced by Kai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Chen. The network helps show where Kai Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 441 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment Hit paper breakdown → | 2008 | 1165 |
| 2 | Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects Hit paper breakdown → | 2006 | 816 |
| 3 | 2008 | 467 | |
| 4 | 2010 | 434 | |
| 5 | 2010 | 422 | |
| 6 | 2008 | 381 | |
| 7 | 2002 | 342 | |
| 8 | 2006 | 307 | |
| 9 | 2010 | 243 | |
| 10 | PET of vascular endothelial growth factor receptor expression. | 2006 | 234 |
| 11 | 2011 | 217 | |
| 12 | 2018 | 216 | |
| 13 | 2007 | 212 | |
| 14 | 2014 | 198 | |
| 15 | 2001 | 188 | |
| 16 | 2010 | 184 | |
| 17 | 2009 | 179 | |
| 18 | 2013 | 176 | |
| 19 | 2008 | 175 | |
| 20 | 2008 | 175 |
About Kai Chen
Kai Chen is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Biomedical Engineering, having authored 441 papers that have together received 17.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (35 papers), Radiopharmaceutical Chemistry and Applications (30 papers), Nanoplatforms for cancer theranostics (26 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Peptidase Inhibition and Analysis (18 papers), Cell Adhesion Molecules Research (17 papers), Medical Imaging Techniques and Applications (17 papers) and Cancer, Hypoxia, and Metabolism (16 papers). The work is most often cited by research in Biomaterials (3.4k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations), Immunology and Allergy (616 citations), Cancer Research (1.4k citations) and Biomedical Engineering (4.3k citations). Kai Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qizhen Cao, Jin Xie, Weibo Cai, Zibo Li, Peter S. Conti, John F. Keaney, Xiaoyuan Chen, Zhen Cheng, Hongjie Dai and Zhuang Liu. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Amino Acids, Frontiers in Oncology, Journal of Nuclear Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.